GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Cyclically Adjusted PS Ratio

Level Bio AB (XSAT:LEVBIO) Cyclically Adjusted PS Ratio : 0.51 (As of Jun. 09, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Level Bio AB's current share price is kr0.288. Level Bio AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr0.57. Level Bio AB's Cyclically Adjusted PS Ratio for today is 0.51.

The historical rank and industry rank for Level Bio AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

XSAT:LEVBIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.4   Med: 1.84   Max: 7.67
Current: 0.51

During the past years, Level Bio AB's highest Cyclically Adjusted PS Ratio was 7.67. The lowest was 0.40. And the median was 1.84.

XSAT:LEVBIO's Cyclically Adjusted PS Ratio is ranked better than
87.79% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.5 vs XSAT:LEVBIO: 0.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Level Bio AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr0.087. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Level Bio AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Level Bio AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Cyclically Adjusted PS Ratio Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 3.20 5.48 1.40 0.72

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 1.24 1.00 0.72 0.54

Competitive Comparison of Level Bio AB's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Level Bio AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Cyclically Adjusted PS Ratio falls into.



Level Bio AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Level Bio AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.288/0.57
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Level Bio AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.087/132.2054*132.2054
=0.087

Current CPI (Mar. 2024) = 132.2054.

Level Bio AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.096 99.788 0.127
201406 0.099 100.432 0.130
201412 0.000 100.225 0.000
201503 0.102 99.950 0.135
201506 0.101 99.995 0.134
201509 0.089 100.228 0.117
201512 0.161 100.276 0.212
201603 0.099 100.751 0.130
201606 0.104 101.019 0.136
201609 0.136 101.138 0.178
201612 0.172 102.022 0.223
201703 0.135 102.022 0.175
201706 0.000 102.752 0.000
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.071 103.962 0.090
201806 0.000 104.875 0.000
201809 0.088 105.679 0.110
201812 0.105 105.912 0.131
201903 0.068 105.886 0.085
201906 0.098 106.742 0.121
201909 0.066 107.214 0.081
201912 0.089 107.766 0.109
202003 0.120 106.563 0.149
202006 0.117 107.498 0.144
202009 0.093 107.635 0.114
202012 0.115 108.296 0.140
202103 0.184 108.360 0.224
202106 0.251 108.928 0.305
202109 0.110 110.338 0.132
202112 0.180 112.486 0.212
202203 0.209 114.825 0.241
202206 0.095 118.384 0.106
202209 0.092 122.296 0.099
202212 0.153 126.365 0.160
202303 0.133 127.042 0.138
202306 0.088 129.407 0.090
202309 0.112 130.224 0.114
202312 0.077 131.912 0.077
202403 0.087 132.205 0.087

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Level Bio AB  (XSAT:LEVBIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Level Bio AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines